ArticleWorld journal of surgical oncology2025

The efficacy and safety of a taxane-based chemotherapy regimen combined with a PD-1 inhibitor in HNSCC: a multicenter real-world study.

Min Ouyang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.